TrialEuropean heart journal2012

Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial.

Peter S Sever et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.